# Alimentiv: GI CRO \| Gastroenterology Clinical Trials > We are a specialized gastrointestinal CRO delivering full\-service clinical trial management services, central imaging, biomarkers, \& more\. Generated by Yoast SEO v28.2, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Clinical Trial Services](https://alimentiv.com/services/clinical-trial-services/) - [ESG Strategy](https://alimentiv.com/about-us/esg-strategy/) - [Home](https://alimentiv.com/) - [Multi\-Year Accessibility Plan](https://alimentiv.com/multi-year-accessibility-plan/) - [AI\-Powered Endoscopy Solutions](https://ec2-3-97-67-81.ca-central-1.compute.amazonaws.com/services/medical-imaging-solutions/ai-powered-endoscopy-solutions/) ## Events - [United European Gastroenterology Week \(UEGW\)](https://alimentiv.com/events/united-european-gastroenterology-week-uegw/) - [7th SEBRADII 2026](https://www.alimentiv.com/events/sebradii-2026/) - [European Crohn’s and Colitis Organisation \(ECCO\) 2026](https://alimentiv.com/events/ecco-2026/) - [Digestive Disease Week® \(DDW\)](https://alimentiv.com/events/ddw/) - [AOCC 2026](https://alimentiv.com/events/aocc-2026/) ## News - [Alimentiv Experts Share Latest Advancements in GI Clinical Trials at UEG Week 2025](https://alimentiv.com/news/alimentiv-experts-share-latest-advancements-in-gi-clinical-trials-at-ueg-week-2025/) - [Alimentiv and PathwaysGI Partner to bring AI\-Based Cumulative Disease Score \(CDS\) to Ulcerative Colitis Trials](https://alimentiv.com/news/pathwaysgi-partnership-ai-ml-endoscopy-disease-assessment/) - [Alimentiv, Summit Clinical Research Announce Collaboration to drive Non\-Alcoholic Steatohepatitis \(NASH\) Clinical Trials](https://www.alimentiv.com/news/alimentiv-summit-clinical-research-announce-collaboration-to-drive-non-alcoholic-steatohepatitis-nash-clinical-trials/) - [Alimentiv to Present Key Insights Into GI Research With Multiple Presentations and Posters at the 20th ECCO Congress](https://alimentiv.com/news/alimentiv-to-present-key-insights-at-the-20th-ecco-congress/) - [Alimentiv Selects Veeva Vault to Launch eTMF Solution](https://alimentiv.com/news/alimentiv-selects-veeva-vault-to-launch-etmf-solution/): London, ON, CANADA, Release: August 12, 2021 –Alimentiv, Inc\. announced today the launch of their new eTMF solution in partnership with Veeva Vault eTMF, offering sponsors real\-time data and secure access to all clinical documentation throughout the clinical trial lifecycle\. As part of its strategy to modernize its technology landscape, Alimentiv selected Vault eTMF to improve ## Resource - [A Decade of Dedication to Patients and Progress: An Interview with Nadine Chomyc](https://alimentiv.com/resources/a-decade-of-dedication-to-patients-and-progress/) - [A CRA’s Perspective on Purpose, People, and Progress: An Interview with Mandi Miller](https://alimentiv.com/resources/a-cras-perspective-on-purpose-people-and-progress/) - [A Practical Look at Sample Size Re\-Estimation of the Promising Zone Design](https://alimentiv.com/resources/a-practical-look-at-sample-size-re-estimation-of-the-promising-zone-design/) - [Different Types of Clinical Trial Designs](https://alimentiv.com/resources/different-types-of-clinical-trial-designs/) - [Advancing Celiac Disease Clinical Trials](https://www.alimentiv.com/resources/advancing-celiac-disease-clinical-trials/) ## Publications - [Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta\-Analysis](https://alimentiv.com/publication/placebo-rates-in-crohns-disease-randomized-clinical-trials/) - [Meta\-Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled Trials](https://alimentiv.com/publication/meta-analysis-evaluating-placebo-rates-across-outcomes-in-eosinophilic-oesophagitis-randomised-controlled-trials/) - [Efficacy and Safety of Advanced Combination Treatment in Immune\-Mediated Inflammatory Disease: A Systematic Review and Meta\-Analysis of Randomized Controlled Trials](https://alimentiv.com/publication/efficacy-and-safety-of-advanced-combination-treatment-in-immune-mediated-inflammatory-disease-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/) - [Responsiveness of Different Disease Activity Indices in Moderate\-To\-Severe Ulcerative Colitis](https://alimentiv.com/publication/responsiveness-of-different-disease-activity-indices-in-moderate-to-severe-ulcerative-colitis/) - [Management of Complications in Patients With an Ileostomy: An Umbrella Review of Systematic Reviews for the Endotrial Consortium](https://alimentiv.com/publication/management-of-complications-in-patients-with-an-ileostomy-an-umbrella-review-of-systematic-reviews-for-the-endotrial-consortium/) ## Leadership - [Geert D’Haens, MD, PhD, AGAF](https://alimentiv.com/about-us/our-experts/geert-dhaens/) - [Evan S\. Dellon, MD, MPH](https://alimentiv.com/about-us/our-experts/evan-dellon/) - [Christopher Ma, MD](https://3.97.67.81/about-us/our-experts/christopher-ma/) - [Bruce Sands, MD, MS](https://alimentiv.com/about-us/our-experts/bruce-sands/) - [Nick Powell, MD](https://alimentiv.com/about-us/our-experts/nick-powell-md/) ## Optional - [Sitemap index](http://alimentiv.com/sitemap_index.xml)